120 related articles for article (PubMed ID: 16530511)
1. HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation.
Belli LS; Burra P; Poli F; Battista Alberti A; Silini E; Zavaglia C; Fagiuoli S; Prando D; Espadas de Arias A; Boninsegna S; Tinelli C; Scalamogna M; de Carlis L; Pinzello G
Gastroenterology; 2006 Mar; 130(3):695-702. PubMed ID: 16530511
[TBL] [Abstract][Full Text] [Related]
2. Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation.
Belli LS; Zavaglia C; Alberti AB; Poli F; Rondinara G; Silini E; Taioli E; de Carlis L; Scalamogna M; Forti D; Pinzello G; Idèo G
Hepatology; 2000 Jun; 31(6):1345-50. PubMed ID: 10827162
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
[TBL] [Abstract][Full Text] [Related]
4. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
5. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation.
Langrehr JM; Puhl G; Bahra M; Schmeding M; Spinelli A; Berg T; Schönemann C; Krenn V; Neuhaus P; Neumann UP
Liver Transpl; 2006 Apr; 12(4):644-51. PubMed ID: 16555324
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center.
Walter T; Dumortier J; Guillaud O; Hervieu V; Scoazec JY; Boillot O
Liver Transpl; 2007 Feb; 13(2):294-301. PubMed ID: 17256784
[TBL] [Abstract][Full Text] [Related]
7. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Cabrera R; Shuster JJ; Theriaque D; Reed AI; Hemming AW; Liu C; Crawford JM; Nelson DR
Liver Transpl; 2004 Oct; 10(10):1240-7. PubMed ID: 15376304
[TBL] [Abstract][Full Text] [Related]
8. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
Selzner N; Girgrah N; Lilly L; Guindi M; Selzner M; Therapondos G; Adeyi O; McGilvray I; Cattral M; Greig PD; Grant D; Levy G; Renner EL
Liver Transpl; 2008 Dec; 14(12):1778-86. PubMed ID: 19025914
[TBL] [Abstract][Full Text] [Related]
9. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen DR markers as predictors of progression to liver transplantation in patients with chronic hepatitis C.
Brandhagen DJ; Gross JB; Poterucha JJ; Germer JJ; Czaja AJ; Smith CI; Ribeiro AC; Guerrero RB; Therneau TM; Schiff E; Gordon FD; Wiesner RH; Persing DH
Am J Gastroenterol; 2000 Aug; 95(8):2056-60. PubMed ID: 10950057
[TBL] [Abstract][Full Text] [Related]
11. Viral load 1 week after liver transplantation, donor age and rejections correlate with the outcome of recurrent hepatitis C.
Ciccorossi P; Maina AM; Oliveri F; Petruccelli S; Leandro G; Colombatto P; Moriconi F; Mosca F; Filipponi F; Bonino F; Brunetto MR
Liver Int; 2007 Jun; 27(5):612-9. PubMed ID: 17498245
[TBL] [Abstract][Full Text] [Related]
12. Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients.
Berenguer M; Aguilera V; Prieto M; San Juan F; Rayón JM; Benlloch S; Berenguer J
Liver Transpl; 2006 May; 12(5):762-7. PubMed ID: 16528713
[TBL] [Abstract][Full Text] [Related]
13. A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection.
do O NT; Eurich D; Schmitz P; Schmeding M; Heidenhain C; Bahra M; Trautwein C; Neuhaus P; Neumann UP; Wasmuth HE
Liver Transpl; 2012 Mar; 18(3):298-304. PubMed ID: 22139994
[TBL] [Abstract][Full Text] [Related]
14. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C.
Toniutto P; Fabris C; Falleti E; Cussigh A; Fontanini E; Bitetto D; Fornasiere E; Minisini R; De Feo T; Marangoni F; Pirisi M
Liver Int; 2008 Feb; 28(2):257-63. PubMed ID: 17900242
[TBL] [Abstract][Full Text] [Related]
16. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
[TBL] [Abstract][Full Text] [Related]
17. Patterns of recurrent hepatitis C after liver transplantation in a recent cohort of patients.
Khettry U; Huang WY; Simpson MA; Pomfret EA; Pomposelli JJ; Lewis WD; Jenkins RL; Gordon FD
Hum Pathol; 2007 Mar; 38(3):443-52. PubMed ID: 17188331
[TBL] [Abstract][Full Text] [Related]
18. Is early recurrence of hepatitis C associated with biliary anastomotic stricture after liver transplantation?
Fujita S; Fujikawa T; Mizuno S; Reed AI; Kim RD; Howard RJ; Firpi RJ; Nelson DR; Hemming AW
Transplantation; 2007 Dec; 84(12):1631-5. PubMed ID: 18165775
[TBL] [Abstract][Full Text] [Related]
19. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.
Botha JF; Thompson E; Gilroy R; Grant WJ; Mukherjee S; Lyden ER; Fox IJ; Sudan DL; Shaw BW; Langnas AN
Liver Int; 2007 Aug; 27(6):758-63. PubMed ID: 17617118
[TBL] [Abstract][Full Text] [Related]
20. Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantation.
Selzner M; Kashfi A; Selzner N; McCluskey S; Greig PD; Cattral MS; Levy GA; Lilly L; Renner EL; Therapondos G; Adcock LE; Grant DR; McGilvray ID
Liver Transpl; 2009 Oct; 15(10):1288-95. PubMed ID: 19790152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
